Tag: Israel

November 15, 2019

Isracann Biosciences Announces OTC Trading Symbol Change to “ISCNF”, Effective November 15, 2019

Isracann Biosciences Inc. is pleased to announce that the FINRA has approved the Company’s request to change its OTC ticker...
November 14, 2019

Isracann Biosciences Hires Expert Consultancy LinC to Steer Israeli Cannabis Project

Isracann Biosciences high quality cannabis producer for both domestic and European export sales, has engaged the services of LinC by...
November 12, 2019

Medical Cannabis Plays Chase Investor Interest Amid Downturn

The changing landscape for marijuana investing in Canada is pushing advanced medical-grade cannabis plays to establish differentiators.
November 5, 2019

CSE Expands International Reach with Israeli Cannabis Firm’s Debut

Israel-based marijuana firm IM Cannabis made its public debut on Monday after its shares started trading on the CSE.
November 5, 2019

Isracann Biosciences Advances Architectural and Security Plans for Israeli Project

Isracann Biosciences announced operational updates regarding the engagement of two leading consultancies within the early-stage Israeli cannabis sector.
October 28, 2019

Isracann Biosciences Launches Phase One Facility Development Program in Israel

Isracann Biosciences Inc. (CSE:IPOT) is pleased to provide an operative overview and update regarding facility development activities in Israel.
October 24, 2019

Isracann Biosciences: Israel’s First Pure-Play Cannabis Company

Isracann Biosciences Inc. (CSE:IPOT) has launched its campaign on the Investing News Network's cannabis channel.